Autologous EBV Specific CTLs for Prophylaxis and Therapy of EBV Lymphoma Post Solid Organ Transplant.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2015
Price : $35 *
At a glance
- Drugs Baltaleucel-T (Primary)
- Indications Epstein-Barr virus infections
- Focus Adverse reactions; Pharmacokinetics
- Acronyms EUCLID
- 15 Jun 2015 According to Atara Biotherapeutics media release, data has been presented at the 2015 American Society of Clinical Oncology Annual Meeting.
- 09 Aug 2014 New trial record